| abstract |
The invention discloses a method to identify proteins involved in the ISP. The invention also discloses suitable targets for the development of new therapeutics to treat, prevent or ameliorate pathological conditions associated with dysregulation of the ISP. The invention also relates to methods to treat, prevent or ameliorate said conditions and pharmaceutical compositions therefor, as well as to a method to identify compounds with therapeutic usefulness to treat pathological conditions associated with dysregulation of the ISP. |